Skip to main content
Tech.euFundingExplorerBeta

Resmonics

Resmonics combines deep learning & respiratory medicine research to offer the 1st CE-certified early-warning system of its kind that helps patients with chronic respiratory diseases manage their condition.

Resmonics has raised €137k across 1 funding round from 1 investor, most recently a round in Jun 2021. Based in Zurich, Switzerland; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€137k
€136,774
Funding rounds
1
Investors
1
distinct backers
Active since
2021-06
latest 2021-06

Funding by year

EUR raised per year
Resmonics — funding by year — interactive chart.
Data table
Resmonics — funding by year
2021€137k

Signals

High confidence
Raise-next likelihood6
base rate 30% for Other
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▼ Low backer re-investment

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 round
DateStageAmountInvestors
2021-06-24Other€137kVenture KickView deal →

Investors

1

Related news

Similar companies

same sector or country

Global coverage: FundingData